Many experiments have proven that PGs are directly involved in Inflammatory bowel disease (IBD) and Colorectal carcinoma (CRC); PGE2 controls the pro-inflammatory and tumor-promoting effect of COX-2 in both IBD and CRC [68]. The gene discussed is PTGS2; the disease is neoplasm.